pre-clinical - OmicsDI

OmicsDI

Browse
Submit Data
Databases
API

39908 Results

Show all Save search Copy query

Show results for

Unknown (33483)
Transcriptomics (2888)
Genomics (2714)
Proteomics (492)
Metabolomics (86)
Other (75)
Clinical (73)
Genomic (41)
Methylation profiling (40)
Models (13)
Multiomics (3)

Organisms

Homo sapiens (2296)
Mus musculus (750)
Rattus norvegicus (85)
Bos taurus (42)
Arabidopsis thaliana (35)
Macaca mulatta (28)
Sus scrofa (26)
Drosophila melanogaster (24)
Danio rerio (23)
Caenorhabditis elegans (22)
Gallus gallus (17)
Ovis aries (16)
Saccharomyces cerevisiae (15)
Macaca fascicularis (12)
Glycine max (6)
Escherichia coli (6)
Biomphalaria glabrata (4)
Oryza sativa (4)
Salmonella enterica subsp. enterica serovar Typhimurium (4)
Oncorhynchus nerka (3)
Macaca nemestrina (3)
Strongyloides ratti (3)
Drosophila simulans (3)
Xenopus laevis (3)
Medicago truncatula (3)
Apis mellifera (3)
Zea mays (3)
Anopheles gambiae (3)
Mycobacterium tuberculosis (3)
Mammalia (1)

Organisms

Homo sapiens (1188)
Mus musculus (385)
Rattus norvegicus (28)
Macaca mulatta (25)
Danio rerio (10)
Canis lupus familiaris (8)
Sus scrofa (8)
human gut metagenome (8)
Bos taurus (6)
Caenorhabditis elegans (5)
Arvicanthis niloticus (4)
Sus scrofa domesticus (4)
Staphylococcus aureus (4)
Mycobacterium tuberculosis (4)
unidentified (3)
Mesocricetus auratus (3)
Plasmodium falciparum (3)
Macaca fascicularis (3)
human metagenome (3)
Bacteria (3)
Mustela putorius furo (2)
human blood metagenome (2)
Mycobacteroides abscessus (2)
Gallus gallus (2)
Ovis aries (2)
mouse gut metagenome (2)
Mycobacterium tuberculosis X122 (1)
Mycobacterium avium subsp. paratuberculosis K-10 (1)
Escherichia coli ATCC 25922 (1)
Saccharomyces cerevisiae YJM451 (1)

Repository

ENA (2280)
biostudies-arrayexpress (1942)
geo (1269)
pride (280)
EGA (271)
MetaboLights (77)
MassIVE (72)
dbGaP (41)
jPOST (29)
iProX (23)
PeptideAtlas (22)
PanoramaPublic (18)
BioModels (13)
GNPS (9)
LINCS (4)
PAXDB (3)
EVA (2)
GPMDB (1)

Tissue

Cell culture (45)
Blood plasma (34)
Blood serum (22)
Others (17)
Epithelial cell (15)
Permanent cell line cell (14)
Blood (9)
Liver (9)
Lung (9)
Brain (7)
Fibroblast (7)
Macrophage (6)
Skin (6)
Cerebrospinal fluid (5)
Early embryonic cell (5)
Heart (5)
T cell (5)
Urine (5)
B cell (4)
Hepatocyte (4)
Placenta (4)
Saliva (4)
Stem cell (4)
Blood platelet (3)
Breast (3)
Cell suspension culture (3)
Kidney (2)
Digestive System (1)
Lung (1)
Plasma Non-glyco (1)

Disease

Normal (7)
Multiple myeloma (7)
Chronic lymphocytic leukemia (6)
Alzheimer's disease (3)
Prostate cancer (2)
Astrocytoma (1)
Ovarian cancer patient invasive malignant (1)
Metastatic colorectal cancer (1)
Early onset preeclampsia (1)
CLL (1)
High grade glioblastoma (1)
T. circumcincta infection (1)
Multibacillary (1)
Phyllodes tumor (1)
Hign immune pressure (1)
Infiltrating ductal carcinoma (1)
Scrapie infected (1)
Liposarcoma (1)
Untreated prostate cancer (1)
Mesothelioma (1)
Gestational diabetes mellitus (1)
Simian immunodeficiency virus (1)
Acute lymphoblastic leukemia (1)
Colorectal cancer (1)
Disease controled patient (1)
Colon adenocarcinoma (1)
Acute myocardial infarction (1)
Normal (1)
Megakaryoblastic leukemia (1)
Disease controled patient (1)

Technology Type

Mass spectrometry (53)
Mass spectrometry assay (13)
NMR spectroscopy (10)
Illumina HiSeq 2000 (6)
Illumina HiSeq 2500, ILLUMINA (4)
Fluorescence imaging (4)
Fluorescence intensity (4)
NMR spectroscopy assay (3)
Illumina CytoSNP 12 bead array, nanostring (1)
ILLUMINA, Illumina HiSeq 1000 (1)
NextSeq 500, ILLUMINA (1)
ABI_SOLID, Illumina HiSeq 2000, Illumina 450K, AB 5500xl Genetic Analyzer, AB 5500 Genetic Analyzer, ILLUMINA (1)
ILLUMINA, Illumina HiSeq 4000, Illumina HiSeq 2500 (1)
Illumina HiSeq 2500, ILLUMINA, Illumina MiSeq, NextSeq 500 (1)
HiSeq X Ten, ILLUMINA, Illumina HiSeq 2500 (1)
ILLUMINA, Illumina HiSeq 2500 (1)
Illumina HumanMethylation 450K (1)
Illumina 450K-chip (methylation data) (1)
Illumina HiSeq 4000, Illumina HiSeq 2500, ILLUMINA (1)
Affymetrix SNP 6.0 (1)
Illumina HiSeq 2000, Illumina HiSeq 2500 (ILLUMINA), ILLUMINA, Illumina HiSeq 2500 (1)
Illumina HiSeq 2500 (ILLUMINA), Illumina HiSeq 2000, Illumina HiSeq 2500, ILLUMINA (1)
ILLUMINA, Illumina HiSeq 2500, Illumina HiSeq 2000 (1)
Illumina HiSeq 2000, Affymetrix SNP 6.0 (1)
Illumina 2.5M, Illumina HiSeq 2000 (1)
ILLUMINA, Illumina HiSeq 2000 (1)
Illumina HiSeq 2500 (1)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Illumina HiSeq 2000, ILLUMINA (1)
Illumina Genome Analyzer II (1)

Instrument Platform

Illumina NovaSeq 6000 (36)
NextSeq 500 (28)
Illumina HiSeq 2500 (21)
Illumina HiSeq 4000 (14)
NextSeq 550 (11)
Illumina HiSeq 2000 (11)
ScanArray 4000XL [PerkinElmer] (5)
Illumina Genome Analyzer IIx (4)
NextSeq 2000 (4)
GenePix 4000B [Axon Instruments] (3)
Scanning hardware (3)
HiSeq X Ten (3)
Illumina MiSeq (3)
Illumina HiScanSQ (2)
Agilent 2100 Bioanalyzer (2)
G2565AA DNA microarray scanner [Agilent] (2)
Axon- GenePix4000B (2)
418 [Affymetrix] (2)
NextSeq 1000 (2)
None (2)
NA (2)
R (2)
N/A (2)
DNBSEQ-G400 (2)
Illumina HiSeq 3000 (2)
Maxwell® RSC 48 Instrument (Promega, AS8500) (1)
Transrectal ultrasound-guided systematic sampling of prostate tissue (TRUS biopsy) (1)
DNBelab C Series High-throughput Single-cell RNA Library Preparation Set V3.0 (MGI Tech) (1)
DNBelab C-TaiM droplet generator (MGI Tech) (1)
Avatarget 12-well dual-chamber organ-on-chip system; AvatarFlow Organ Chip Flow Initiation Controller System (Avatarget Co., Ltd., Suzhou, China) (1)

Publication Date

2025 (315)
2013 (291)
2014 (284)
2010 (272)
2015 (269)
2024 (258)
2026 (241)
2011 (237)
2012 (222)
2022 (206)
2023 (203)
2021 (148)
2016 (143)
2020 (133)
2019 (103)
2008 (93)
2018 (91)
2009 (86)
2017 (77)
2007 (42)
2005 (20)
2006 (14)
2004 (8)
2003 (3)
2002 (2)

UNIPROT ID/AC

P0CG47 (2)
P62136 (2)
P49841 (2)
Q00987 (2)
P05067 (2)
Q13315 (2)
P04637 (2)
1433S_HUMAN (2)
A0A087WXI2_HUMAN (2)
A0A096LPE2_HUMAN (2)
A1AG1_HUMAN (2)
A1AG2_HUMAN (2)
A1AT_HUMAN (2)
A1BG_HUMAN (2)
A2AP_HUMAN (2)
A2GL_HUMAN (2)
A2MG_HUMAN (2)
AACT_HUMAN (2)
ACTB_HUMAN (2)
ACTG_HUMAN (2)
ACTS_HUMAN (2)
ADIPO_HUMAN (2)
AFAM_HUMAN (2)
AGRG6_HUMAN (2)
ALBU_HUMAN (2)
ALS_HUMAN (2)
AMBP_HUMAN (2)
AMPN_HUMAN (2)
ANGT_HUMAN (2)
ANT3_HUMAN (2)

ENSEMBL ID

ENSG00000170477 (16)
ENSG00000147251 (6)
ENSG00000247315 (5)
ENSG00000229353 (4)
ENSG00000204131 (1)

CHEBI ID

CHEBI:16737 (26)
CHEBI:15428 (23)
CHEBI:16919 (23)
CHEBI:30769 (23)
CHEBI:17368 (19)
CHEBI:15971 (18)
CHEBI:15354 (18)
CHEBI:15891 (18)
CHEBI:17295 (17)
CHEBI:16414 (17)
CHEBI:15603 (16)
CHEBI:32816 (16)
CHEBI:16449 (16)
CHEBI:27897 (16)
CHEBI:17191 (16)
CHEBI:28044 (16)
CHEBI:17895 (15)
CHEBI:16196 (15)
CHEBI:16015 (14)
CHEBI:18050 (14)
CHEBI:17154 (14)
CHEBI:18089 (14)
CHEBI:18183 (14)
CHEBI:28300 (14)
CHEBI:17203 (14)
CHEBI:16027 (11)
CHEBI:16991 (2)
CHEBI:26523 (2)
CHEBI:16761 (2)
CHEBI:15422 (2)

Metabolite Name

Creatinine (17)
Creatine (17)
Taurine (15)
Alanine (14)
Citric acid (14)
Glycine (13)
Hypoxanthine (13)
L-Histidine (12)
Valine (11)
Leucine (11)
Phenylalanine (11)
Citrulline (10)
Glucose (10)
Adenine (10)
Glutamine (10)
Isoleucine (10)
Tryptophan (10)
Hippuric acid (10)
L-Valine (10)
Carnosine (9)
Pyroglutamic acid (9)
Threonine (9)
Proline (9)
Inosine (9)
Succinic acid (9)
Choline (9)
Cholic acid (8)
Uric acid (8)
Oleic acid (8)
Pyruvate (8)

First Public Date

2025 (344)
2024 (279)
2026 (260)
2023 (231)
2014 (211)
2022 (201)
2020 (164)
2019 (149)
2021 (139)
2017 (86)
2018 (77)
2015 (66)
2016 (33)
2013 (27)
2010 (7)
2012 (5)
2011 (1)

Modelling Approach

Ordinary differential equation model (6)
Computational model (4)
Other (1)

Study status

Completed (22)
Recruiting (21)
Not provided (11)
Not yet recruiting (9)
Active, not recruiting (5)
Withdrawn (3)
Ongoing (1)
Terminated (1)

Lab affiliation

iBET – Instituto de Biologia Experimental e Tecnológica, Av. da República, Oeiras, 2780-157, Portugal (14)
Institute for Research in Immunology and Cancer, Department of Biochemistry, Department of Chemistry, Université de Montréal, Québec, Canada H3T 1J4 (9)
Administrerende Direktør • Novo Nordisk Foundation Center for Protein Research (6)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (5)
Emory University (3)
Executive Science Officer, BioFrontiers InstituteDistinguished ProfessorProfessor, Howard Hughes Medical Institute MOLECULAR CELLULAR AND DEVELOPMENTAL BIOLOGY CU DENVER SCHOOL OF MEDICINE (3)
Proteomics Team, Nestlé Institute of Health Sciences, Lausanne, Switzerland (3)
1 Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and HUS Helsinki University Hospital, P.O.Box 263, FI-00029 HUS, Helsinki, Finland 2 Department of Biosciences and Nutrition, Karolinska Institutet, SE-171 76, Stockholm, Sweden. 3 Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. (2)
BCMP, Harvard Medical School, Boston, USA Cancer Biology, Dana-Farber Cancer Institute, Boston, USA (2)
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, United States (2)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (2)
Department of Oncology Pathology, Karolinska Institute, Solna, Sweden (2)
Executive Director, Professor Novo Nordisk Foundation Center for Protein Research Proteomics Program (2)
IRCCS Istituto G Gaslini (2)
Roswell Park Cancer Center Buffalo, NY, USA (2)
School of Nursing and School of Medicine, Department of Neurology, Johns Hopkins University, Baltimore, MD, United States (2)
Systems Arbovirology, Leibniz Institute of Virology, Hamburg, Germany (2)
"Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany" (1)
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Portugal - ICVS/3B’s Associate Lab, PT Government Associated Lab, Portugal (1)
- Platelet Research Lab, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain - Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands - Department of Medicine, University of Oviedo, Oviedo, Spain (1)
1. Department of Molecular Biology, RIMLS, Radboud University 2. Division of Molecular Genetics, Netherlands Cancer Institute (1)
1.Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. 2.Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. (1)
1: Evotec (München) GmbH, Am Klopferspitz 19a, 82151 Martinsried, Germany 2: Cell Signaling Group, Department of Molecular Biology, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany (1)
1Platelet Proteomics Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade Santiago de Compostela; and Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. (1)
1VIB-UGent Center for Medical Biotechnology, VIB, 9052 Ghent, Belgium 2Department of Biomolecular Medicine, Ghent University, 9052 Ghent, Belgium (1)
Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (1)
Angiogenesis and Tumor Microenvironment Lab The Swiss Institute for Experimental Cancer Research (ISREC) School of Life Sciences Ecole Polytechnique Fédérale de Lausanne (EPFL) Swiss Federal Institute of Technology, Lausanne, Switzerland (1)
Associate Professor Systems Virology Department of Translation medicine Faculty of Medicine Lund University Sweden (1)
Baker Heart and Diabetes Institute, Aus (1)
Bavarian Center for Biomolecular Mass Spectrometry Technische Universität München Gregor-Mendel-Straße 4 85354 Freising GERMANY (1)

Keyword

Chemotherapy (3)
Erythromycin (2)
Erythromycin Estolate (2)
Erythromycin Ethylsuccinate (2)
Erythromycin stearate (2)
APC gene (2)
Nonsense mutations (2)
FOLFOX (2)
Colorectal (2)
Prehabilitation (2)
Avelumab (2)
CRC (2)
Capecitabine (2)
Bevacizumab (2)
Oxaliplatin (2)
Cetuximab (2)
Stability of the Septin 9 biomarker (1)
Epi Pro Colon Test (1)
LiverMultiScan (1)
Multiparameter MRI (1)
Functional liver remnant (1)
Portal vein embolisation (1)
Preoperative liver function (1)
Postoperative liver failure (1)
Colo-rectal Surgery (1)
Sleep duration (1)
CAR-T cell (1)
Minimal residue disease (1)
Preparation (1)
Patient empowerment (1)

IsPrivate

False (13)

Submitter Keywords

FAIR-AIML (4)
Machine Learning Model (4)
Ersilia (2)
TransQST (1)
Not Peer Reviewed (1)
Immuno-oncology (1)

Classification

bacteria (23)
viruses (6)
protozoa (3)
fungi (1)

Study type

Transcription profiling by array (1258)
RNA-seq of coding RNA (178)
RNA-seq of non coding RNA (139)
Comparative genomic hybridization by array (43)
MicroRNA profiling by array (41)
Other (39)
Unknown experiment type (35)
ChIP-seq (27)
Proteomic profiling by array (27)
Methylation profiling by array (23)
Transcription profiling by RT-PCR (20)
RNA-seq of total RNA (15)
RNA-seq of coding RNA from single cells (14)
MicroRNA profiling by high throughput sequencing (13)
ChIP-chip by tiling array (8)
DNA-seq (7)
Genotyping by array (6)
Human - High-throughput sequencing (5)
Transcription profiling by tiling array (5)
ChIP-chip by array (5)
Methylation profiling by high throughput sequencing (5)
Transcription profiling by SAGE (2)
One-color microarray (2)
High-throughput sequencing (2)
Animal - High-throughput sequencing (2)
Bisulfite-seq (2)
ATAC-seq (2)
Genotyping by high throughput sequencing (2)
Animal - Two-color microarray (1)
MNase-seq (1)

Release Date

2022 (4669)
2025 (4387)
2023 (4240)
2021 (4207)
2024 (3449)
2020 (2871)
2019 (2198)
2018 (1813)
2017 (1330)
2016 (1232)
2015 (1063)
2014 (864)
2013 (654)
2026 (598)
2012 (489)
2011 (423)
2010 (420)
2009 (189)
2008 (152)
2007 (64)
2005 (43)
2006 (33)
2004 (14)
2003 (7)
2001 (4)
2002 (3)
1999 (2)
2000 (1)
1998 (1)
1982 (1)

Location

Australia (15)
United States (12)
France (9)
United Kingdom (9)
Italy (6)
Canada (5)
Israel (3)
Spain (3)
Belgium (3)
Netherlands (3)
Cyprus (2)
New Zealand (2)
China (2)
Germany (2)
Finland (1)
Slovenia (1)
Ireland (1)
Singapore (1)
Taiwan (1)
Denmark (1)
Bulgaria (1)
Chile (1)
Greece (1)
Russia (1)
Czechia (1)
Brazil (1)
Sweden (1)

Previous page
1 / 3991
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 3991
Next page

Sort by:

Relevance

Page size

Safety and efficacy analysis of in vivo lentiviral gene therapy in pre-clinical ARC syndrome models

2026-04-29 | MTBLS14408 | MetaboLights

Adjunctive ibuprofen in pre-extensively drug-resistant and extensively drug-resistant tuberculosis: a Phase IIA open-label pilot clinical trial

Drug-resistant tuberculosis (TB) remains a major global health challenge. Host-directed therapies (HDTs) aim to limit tissue damage, shorten treatment, and improve outcomes by modulating immune responses. We evaluated the safety and potential efficacy of adjunctive ibuprofen an inexpens...

2026-05-28 | MTBLS13376 | MetaboLights

Development Of Pre-Clinical Murine Models For Fibrolamellar Hepatocellular Carcinoma

PRJNA1048524 | ENA

Pre-clinical models of genetically heterogeneous multiple myeloma reveal immune evasion mechanisms and predict clinical immunotherapy outcomes

PRJNA846769 | ENA

NCIC CTG MA.22 phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer on 2-weekly or 3-weekly schedules

This phase I/II neoadjuvant trial determined maximally-tolerated doses (MTD), dose-limiting toxicities (DLT), response-to-therapy, and explored the role of new response biomarkers. The combination regimens were delivered with acceptable toxicity, good clinical response, inducing changes in tumor RNA...

ORGANISM(S): Homo sapiens

2015-11-11 | E-GEOD-66999 | biostudies-arrayexpress

Pre-clinical proof of principle for orally delivered Th17 antagonist miniproteins

PRJNA1096346 | ENA

Propyzamide and a pre-clinical model of IBD

PRJNA800443 | ENA

The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models

we report characterized the preclinical activity of a new member of this class, the ST1926-derivative ST5589, in lymphomas GEP analysis of 2 lymphoma cell lines with and without treatment

ORGANISM(S): Homo sapiens

2016-01-08 | E-GEOD-66455 | biostudies-arrayexpress

Pre-clinical optimization of MDM2 antagonist treatment of glioblastoma

PRJNA1235692 | ENA

Evaluating pre-clinical models for studying NASH driven HCC.

PRJNA474086 | ENA